SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
4.250
+0.150 (3.66%)
Sep 14, 2026, 4:00 PM EDT - Market closed
← View all transcripts

AGM 2026

Jun 11, 2026

Summary

The meeting covered director elections, auditor ratification, and executive compensation votes. Quorum was met, voting was conducted online, and results will be disclosed in a Form 8-K. Only meeting-related questions were addressed during the Q&A.

Morgan Frank
CEO, Sanuwave Health

Good morning, ladies and gentlemen. Welcome, and thank you for attending the 2026 Annual Meeting of Stockholders of Sanuwave Health Incorporated. This meeting will please come to order. My name is Morgan Frank, Chief Executive Officer of Sanuwave, and I will act as chairman of this meeting. Peter Sorensen, Chief Financial Officer and secretary of the company, will act as secretary of this meeting.

Peter Sorensen
CFO and Secretary, Sanuwave Health

I hereby accept the appointment as secretary of the meeting.

Morgan Frank
CEO, Sanuwave Health

We will host today's meeting through this virtual online platform. Please remember that if you've not already voted, you may vote your shares online at any time during this meeting prior to the closing of the polls. The agenda for this annual meeting is available currently on this website. I encourage you to review the agenda if you have not already done so. Moving to preliminary matters. We will now take care of some preliminary matters before proceeding with the stockholder vote. The company has appointed Kathy Weeden of Broadridge to act as the inspector of the election for this meeting. Mr. Secretary, the original oath of the inspector of election should be filed with the minutes of this meeting. The inspector of election has received the list of stockholders and has requested copies of all proxies given by stockholders in connection with this meeting.

Peter Sorensen
CFO and Secretary, Sanuwave Health

Mr. Chairman, I present to the meeting an affidavit from Broadridge certifying that the notice of annual meeting was mailed to the company stockholders on or about April 29th, 2026. The original affidavit will be filed with the minutes of this meeting.

Morgan Frank
CEO, Sanuwave Health

Mr. Secretary, will you please report to the meeting on the shares of Sanuwave common stock voting together which are present at this meeting.

Peter Sorensen
CFO and Secretary, Sanuwave Health

Mr. Chairman, April 20th, 2026, is the record date fixed by the board of directors for the determination of stockholders entitled to notice of and to vote at this annual meeting. Only holders of Sanuwave common stock at the close of business on that date are entitled to notice of and to vote at this annual meeting. As of the record date, there were 8,598,209 shares of our common stock issued and outstanding. Each share of common stock entitles its holder to cast one vote on any matter to be voted on at the meeting. Under Nevada law and the bylaws of the company, the presence at the meeting in person or by proxy of persons holding at least one half of our outstanding shares of common stock as of the record date will constitute a quorum.

A preliminary count indicated that the holders of record of more than one half of the outstanding shares of common stock are present at this annual meeting. The inspector of election has made an exact count and will submit a formal report on the number of votes present.

Morgan Frank
CEO, Sanuwave Health

Because the quorum is present, we will proceed with the meeting. On to first order of business. This annual meeting has been called for the purposes set forth in the notice of the annual meeting and the proxy statement. Proxy statement sets forth five proposals for the stockholders to vote upon. Number one, to elect five directors, Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller, and James Tyler, to serve until the 2027 annual meeting of stockholders. Number two, to ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31st, 2026. Third, to approve in an advisory non-binding vote the compensation paid to our named executive officers. All stockholders are entitled to vote at this annual meeting. I'm sorry, all stockholders entitled to vote at this annual meeting have the ability to do so online.

If you're a stockholder entitled to vote and have not yet voted, or if you want to change your previously cast vote, please do so via the website used for this meeting. Please remember that if you've already voted by proxy, it is not necessary to vote again. After voting has been completed on all matters on the agenda, we will close the polls. We will now pause for 30 seconds to allow voting. All right. I now declare that the polls are closed. The inspector of election will furnish the secretary with a written report of the final vote count with respect to the proposals, which will be included in the minutes of the meeting. The company will disclose the results of voting in a current report on Form 8-K within four business days. This brings us to the conclusion of the meeting.

That concludes the business for this meeting. The annual meeting is now adjourned. We will now address stockholder questions. If any stockholder would like to ask a question, please submit it through the web portal by typing it in the box on the web portal. In the interest of efficiency, we reserve the right to group questions of a similar nature together, and we may not have time to respond to all questions. As a reminder, we'll only be answering questions that regard to the business before the meeting today and not general corporate questions. Those are best reserved for our earnings calls, which will occur in August of this year. I see one question, which is, could you please update the timeline for the four-cavity applicator mold? As discussed, we're confining questions to the specific matters before this meeting as opposed to general corporate questions.

That's not a question we'll be addressing at this time. Seeing no further questions, I want to thank you all again and thank all of our shareholders for participating in today's annual meeting. Thank you again.

Operator

The conference has now concluded. Thank you for attending today's presentation. You may now dis